SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing intense selling pressure as investors react to reports of a massive financing backstop for OpenAI, sparking concerns over the sustainability of AI capital expenditure and "circular financing" models. While some investors see this as a strategic move to lock in long-term AI demand, the community remains deeply divided, with many debating whether this is a fundamental correction or an opportunity to buy the dip amid broader semiconductor sector weakness.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending after crushing quarterly revenue expectations and confirming a massive long-term backlog, fueling community debate over the company's transition from a construction-heavy builder to a scaled, contracted cash-flow machine. While the community remains highly bullish on the long-term infrastructure thesis, sentiment is currently pressured by broader market volatility, sector-wide sell-offs, and ongoing uncertainty surrounding AI capital expenditure sustainability.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility as investors weigh concerns about potential memory oversupply and sector-wide de-rating following a high-profile Chinese competitor's IPO. While some in the community view the rapid decline as an overreaction that offers a generational buying opportunity ahead of earnings, others warn that shifting sentiment and aggressive technical selling could drive shares toward lower support levels.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a significant sell-off following FDA briefing documents that challenge the statistical methodology and efficacy of its Duchenne muscular dystrophy treatment, deramiocel, ahead of the July 29 advisory committee meeting. The community is sharply divided, with bulls pointing to the company's rebuttal that the FDA used an obsolete, unsigned draft analysis plan, while bears and skeptics express concern over potential data manipulation and the risk of a negative committee vote.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility as traders react to conflicting signals from semiconductor earnings, geopolitical tensions in the Middle East, and fluctuating oil prices. The community remains deeply divided, with many debating whether the current price action represents a massive bear trap for long-term AI-driven growth or a sign of an impending sector-wide correction.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to heightened volatility and a broader semiconductor selloff as investors weigh concerns over AI infrastructure spending against upcoming earnings results. The community remains sharply divided, with many debating if current pullbacks are healthy consolidation or the beginning of a larger rotation out of AI-heavy chip stocks.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is experiencing significant volatility and downside pressure as investors react to a combination of geopolitical tensions, semiconductor sector weakness, and uncertainty ahead of key Federal Reserve and earnings announcements. The community is actively debating the sustainability of AI-driven valuations and the impact of aggressive short-dated hedging, with many traders closely monitoring support levels while expressing frustration over erratic intraday price swings.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as investors digest a secondary offering by the Kim family, which has created a supply-demand imbalance despite the non-dilutive nature of the share sale. The community is actively debating whether this pullback represents a buying opportunity or a warning sign, while bulls remain focused on the long-term potential of the company's U.S.-based advanced packaging footprint and its critical role in the AI hardware supply chain.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Semiconductor stocks are experiencing intense volatility and sector rotation as investors balance strong AI infrastructure demand against concerns over stretched valuations and a possible cooling in capital expenditure. The community remains deeply divided, with many actively debating whether the current pullback represents a healthy consolidation within a long-term AI-driven uptrend or a deeper cyclical correction.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.

MapLight Therapeutics Inc.

MapLight Therapeutics is seeing significant volatility after reporting mixed Phase 2 trial results for its lead schizophrenia candidate, leading to a sharp decline in share price. While some investors are expressing frustration over the clinical miss, the community is actively debating whether the sell-off represents an overreaction, with many citing the company's cash position and potential for future pipeline developments as reasons for a possible rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exclusive: Imunon Says Lead Drug Continues To Show Promise in Advanced Ovarian Cancer Patients

Imunon reports early Phase 2 data showing lower residual disease and higher ctDNA clearance with IMNN-001 in ovarian cancer.read more...

Imunon (IMNN) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Exploring Imunon's Earnings Expectations

Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued

Equity

The trial is evaluating IMNN-001 in the treatment of women with newly diagnosed advanced ovarian cancer. 


Imunon Jumps 96% On Phase 2 Immune Biomarker Data Reveal Ahead of ESMO Congress; Retail Expects ‘Major’ Partnership News Soon

The data highlights promising results for IMNN-001, an IL-12 gene therapy for advanced ovarian cancer, boosting investor optimism ahead of its Phase 3 trial.

Retail Bulls Cheer Imunon’s Pullback From Public Offering, Citing ‘Much Better Funding Options’

Shares jumped 15.5% after hours, as retail traders pointed to “much better funding options” hinted at during the firm’s recent earnings call.

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Imunon Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

The Fed's July 28-29 meeting has markets debating a hold versus a hike, not a cut, with CME FedWatch pricing roughly a 65% chance of no change and rising odds of a September rate increase amid inflation running well above the 2% target. What do you expect the Fed to decide? Drop a comment with when you expect the first cut/hike to be.

What do you expect the Fed to decide at its FOMC meeting?  
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

IMNNImunon Inc

Fundamentals

Latest IMNN News